Penaloza-MacMaster Pablo, Alayo Quazim A, Ra Joshua, Provine Nicholas M, Larocca Rafael, Lee Benjamin, Barouch Dan H
Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02215, United States.
Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02215, United States; Ragon Institute of MGH, MIT, and Harvard, Boston, MA 02114, United States.
Vaccine. 2016 Sep 22;34(41):4955-4963. doi: 10.1016/j.vaccine.2016.08.048. Epub 2016 Aug 24.
T cells are an important component of immune responses, and their function is influenced by their expression of inhibitory receptors. Immunization with alternative serotype adenovirus (Ad) vectors induces highly functional T cell responses with lower programmed cell death 1 (PD-1) expression and increased boostability relative to Ad5 vectors. However, a detailed phenotypic characterization of other inhibitory receptors is lacking, and it is unknown whether Ad5-induced CD8 T cells eventually recover function with time. In this report, we measure the expression of various inhibitory receptors and memory markers during early and late time points following vaccination with Ad5 and alternative serotype Ad vectors. CD8 T cells induced by Ad5 exhibited increased expression of the inhibitory receptor Tim-3 and showed decreased central memory differentiation as compared with alternative serotype Ad vectors, even a year following immunization. Moreover, relative to Ad5-primed mice, Ad26-primed mice exhibited substantially improved recall of SIV Gag-specific CD8 T cell responses following heterologous boosting with MVA or Ad35 vectors. We also demonstrate that low doses of Ad5 priming resulted in more boostable immune responses with lower PD-1 expression as compared to high Ad5 doses, suggesting a role for vector dose in influencing immune dysfunction following Ad5 vaccination. These data suggest that Ad5 vectors induce a long-term pattern of immune exhaustion that can be partly overcome by lowering vector dose and modulating inhibitory signals.
T细胞是免疫反应的重要组成部分,其功能受抑制性受体表达的影响。与Ad5载体相比,用替代血清型腺病毒(Ad)载体免疫可诱导高功能性T细胞反应,程序性细胞死亡1(PD-1)表达降低且增强能力增加。然而,缺乏对其他抑制性受体的详细表型特征描述,并且Ad5诱导的CD8 T细胞最终是否会随时间恢复功能尚不清楚。在本报告中,我们测量了用Ad5和替代血清型Ad载体接种疫苗后早期和晚期不同抑制性受体和记忆标志物的表达。与替代血清型Ad载体相比,即使在免疫一年后,Ad5诱导的CD8 T细胞仍表现出抑制性受体Tim-3表达增加,且中枢记忆分化减少。此外,相对于用Ad5初免的小鼠,用Ad26初免的小鼠在用MVA或Ad35载体进行异源加强免疫后,对SIV Gag特异性CD8 T细胞反应的回忆能力有显著改善。我们还证明,与高剂量Ad5相比,低剂量Ad5初免导致更低的PD-1表达和更强的可加强免疫反应,表明载体剂量在影响Ad5疫苗接种后免疫功能障碍中起作用。这些数据表明,Ad5载体诱导了一种长期的免疫耗竭模式,可通过降低载体剂量和调节抑制信号部分克服。